Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MYRIAD GENETICS INCMYGN · Entity 5953 | E.V.P., General Counsel | September 30, 2018 | October 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MYRIAD GENETICS INC
Report date September 30, 2018 · Filed October 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,174 |
Ending reported balance
After 2018-09-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-09-30 · Disposition to issuer · Disposed 4,998 · Balance 149,718 F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Row 2 · 2018-09-30 · Disposition to issuer · Disposed 5,544 · Balance 144,174 F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2018 Filed Oct 2, 2018 12:53 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,544 | $46.00 | $255,024.00 |
DisclosureSEC source: 0001206386-18-000020 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,174 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 12:53 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 4,998 | $46.00 | $229,908.00 |
DisclosureSEC source: 0001206386-18-000020 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,718 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:40 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,544 | $46.65 | $258,627.60 |
DisclosureSEC source: 0001206386-18-000018 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,716 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:08 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-18-000016 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,260 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:13 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,314 | $46.35 | $292,653.90 |
DisclosureSEC source: 0001206386-18-000014 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,260 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $23.11 | $0.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · derivative · entry 7 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2020-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,672 | $0.00 Strike: $23.11 | $0.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · derivative · entry 6 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 30,672 shares Expires 2020-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 7,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 5 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,574 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 40,000 | $42.02 | $1,680,652.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 4 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,197 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 40,000 | $23.11 | $924,400.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 30,672 | $44.00 | $1,349,568.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,197 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 30,672 | $23.11 | $708,829.92 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 20:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 33,000 | $0.00 Strike: $30.34 | $0.00 |
DisclosureSEC source: 0001206386-18-000010 · edgardoc.xml · derivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,000 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 20:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 33,000 | $40.00 | $1,320,000.00 |
DisclosureSEC source: 0001206386-18-000010 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,197 Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 20:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 33,000 | $30.34 | $1,001,220.00 |
DisclosureSEC source: 0001206386-18-000010 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:43 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 33,139 | $0.00 Strike: $30.34 | $0.00 |
DisclosureSEC source: 0001206386-18-000008 · edgardoc.xml · derivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,139 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:43 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 33,139 | $38.00 | $1,259,282.00 |
DisclosureSEC source: 0001206386-18-000008 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,769 Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:43 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 33,139 | $30.34 | $1,005,437.26 |
DisclosureSEC source: 0001206386-18-000008 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 37,654 | $0.00 Strike: $30.12 | $0.00 |
DisclosureSEC source: 0001206386-18-000006 · edgardoc.xml · derivative · entry 5 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,654 shares Expires 2019-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,775 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001206386-18-000006 · edgardoc.xml · derivative · entry 4 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,775 shares Expires 2021-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 3,775 | $26.49 | $99,999.75 |
DisclosureSEC source: 0001206386-18-000006 · edgardoc.xml · nonDerivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 37,654 | $40.25 | $1,515,611.15 |
DisclosureSEC source: 0001206386-18-000006 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,994 Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 37,654 | $30.12 | $1,134,138.48 |
DisclosureSEC source: 0001206386-18-000006 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2018 Filed Jan 19, 2018 19:26 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $30.12 | $0.00 |
DisclosureSEC source: 0001206386-18-000004 · edgardoc.xml · derivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,654 Underlying: Common Stock · 40,000 shares Expires 2019-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 18, 2018 Filed Jan 19, 2018 19:26 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 40,000 | $38.25 | $1,530,000.00 |
DisclosureSEC source: 0001206386-18-000004 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,994 Read SEC document |
| January 18, 2018 Filed Jan 19, 2018 19:26 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 40,000 | $30.12 | $1,204,800.00 |
DisclosureSEC source: 0001206386-18-000004 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 20:18 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 13,759 | $36.25 | $498,763.75 |
DisclosureSEC source: 0001206386-18-000002 · edgardoc.xml · nonDerivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,994 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 05, 2018 Filed Jan 16, 2018 20:18 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-18-000002 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,753 Read SEC document |
| October 04, 2017 Filed Jan 16, 2018 20:18 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-18-000002 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,385 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 20:34 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,291 | $36.18 | $191,428.38 |
DisclosureSEC source: 0001206386-17-000008 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,885 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 20:34 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,869 | $36.18 | $212,340.42 |
DisclosureSEC source: 0001206386-17-000008 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,176 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2017 Filed Sep 19, 2017 21:24 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,684 | $33.05 | $220,906.20 |
DisclosureSEC source: 0001206386-17-000006 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,045 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-17-000004 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,729 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| June 22, 2017 Filed Jul 17, 2017 20:27 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GiftCommon Stock | 5,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-17-000002 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,729 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:48 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,646 | $20.58 | $75,034.68 |
DisclosureSEC source: 0001206386-16-000020 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,134 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:31 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 4,606 | $20.92 | $96,357.52 |
DisclosureSEC source: 0001206386-16-000018 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,780 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:55 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 45,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-16-000016 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,386 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.